GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

America Great Health AAGH · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$294,700

FY2015FY2024

Net income

−$1.2m

FY2015FY2024

Free cash flow

−$615,600

FY2015FY2024

Shareholders' equity

−$5.2m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Revenue$294,700$204,300$104,700$195,700————$43,400
Gross profit$169,800$168,600−$1.5m$51,400————−$15,900
Operating income−$782,700−$492,600−$4.7m−$243,600−$46,800−$58,200−$48,400—−$660,100
Net income−$1.2m−$761,400−$4.9m−$269,100−$65,000−$59,400−$967,000−$1.1m−$644,500
Diluted earnings per share-0.00—-0.00——————

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Total assets$323,500$299,100$336,100$623,000$100$13,100$3,900$249,500$24,300
Cash and short-term investments$54,900$54,200$62,600$396,100$100—$3,800—$24,300
Total liabilities$5.6m$4.6m$4.1m$1.1m$168,100$120,600$52,000$1.3m$1.0m
Debt$2.4m$2.3m$1.2m$582,200————$10,000
Shareholders' equity−$5.2m−$4.3m−$3.8m−$467,800−$168,000−$107,500−$48,100−$1.1m−$997,800
Shares outstanding21,123m21,093m21,090m20,439m20,236m20,236m20,182m20,049m19,981m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Cash from operations−$615,600−$389,800−$1.5m−$329,200−$27,800−$46,800−$51,200−$485,300−$69,300
Capital spending—−$44,400−$16,900−$12,700—————
Free cash flow−$615,600−$434,200−$1.5m−$341,900−$27,800−$46,800−$51,200−$485,300−$69,300

Latest quarters

By quarter end

Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023
Revenue$56,200$90,900$140,100$95,700$94,000$91,200$13,800$74,700
Gross profit$49,800$83,100$128,800−$8,700$82,100$82,700$13,600$74,700
Operating income−$85,300−$120,500−$70,900−$419,600−$134,300−$153,900−$74,900−$157,600
Net income−$158,400−$193,100−$145,400−$589,300−$226,600−$247,700−$157,000−$241,800
Total assets$267,000$281,600$305,600$323,500$333,400$323,600$276,900$299,100
Cash and short-term investments$36,900$36,000$49,000$54,900$51,700$72,300$54,600$54,200
Debt$2.6m$2.5m$2.5m$2.4m$1.8m$1.8m$1.8m$1.8m
Shareholders' equity−$5.6m−$5.5m−$5.3m−$5.2m−$4.8m−$4.7m−$4.6m−$4.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.6%——
Operating income47.6%75.7%8.3%
Net income65.5%79.8%13.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin67.8%-136.9%——
Operating margin-255.6%-782.2%——
Net margin-397.2%-890.3%——

Valuation history

At each fiscal year end

FY2024FY2023FY2020
Price to sales0.00.00.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return12344%-11%2716%-57%562%16155%180%1294215%84%69%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-for-1 split · 10 Oct 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.